Login to Your Account



Aspreva Prices IPO, Raises $79.2M For CellCept Work

By Randall Osborne


Monday, March 7, 2005
Almost a year after its $57 million Series A private equity financing, Aspreva Pharmaceuticals Inc. priced its initial public offering of 7.2 million shares at $11 per share (C$13.68), raising $79.2 million for the Victoria, British Columbia-based firm. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription